Canadian Hospital Specialties Limited Joins AdvaMed®, the World’s Leading Medical Technology Trade Association

Learn how AdvaMed® member companies can support earthquake relief efforts in Columbia through medical supply donations, logistics assistance, financial contributions, and other humanitarian response initiatives.

WINNIPEG, MANITOBA, CANADA, August 20, 2026 /EINPresswire.com/ — Cubresa Inc., a global leader in clinical and preclinical molecular imaging technologies, today announced that it has received FDA 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking Cubresa BrainPET™ scanner.

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner. 

Global memory chip shortages are creating growing challenges for the medical technology sector. These disruptions could affect timely patient care and innovation, underscoring the need for collaboration with memory chip suppliers and federal partners to safeguard access to essential medical technologies.

Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.

“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Jacque Engle, Vice President of Marketing & Communication and Juli Goldstein, Vice President of Government Affairs & Market Access at Digital Diagnostics.

Explore AdvaMed’s Q2 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation and strengthening the medtech industry.

Learn how AdvaMed® member companies can support earthquake relief efforts in Venezuela through medical supply donations, logistics assistance, financial contributions, and other humanitarian response initiatives.